Abstract
No public abstract is available from the verified source records.
Open public full textRights: ALLOWED · cc-by · Source: journal-auto-sync:external:CROSSREF_ISSN
Open the manuscript using the link above. DOC files open in Word or a compatible document reader.
Abstract
Rights: ALLOWED · cc-by · Source: journal-auto-sync:external:CROSSREF_ISSN
Open the manuscript using the link above. DOC files open in Word or a compatible document reader.
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Open the manuscript using the link above. DOC files open in Word or a compatible document reader.
Current Concepts on the Pathogenesis of Systemic Sclerosis
10.1007/s12016-021-08889-8 · 2023
Case study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trial
10.1016/j.omta.2025.201663 · 2026
Systemic sclerosis
10.1016/s0140-6736(17)30933-9 · 2017
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial
10.1016/s2665-9913(22)00131-x · 2022
CAR T-cell therapy in autoimmune diseases
10.1016/s0140-6736(23)01126-1 · 2023
No additional external references are available.